Logo image of ATON

ALPHATON CAPITAL CORP (ATON) Stock Fundamental Analysis

USA - NASDAQ:ATON - VGG7185A1369 - Common Stock

5.13 USD
+0.01 (+0.2%)
Last: 10/24/2025, 8:09:48 PM
5.09 USD
-0.04 (-0.78%)
After Hours: 10/24/2025, 8:09:48 PM
Fundamental Rating

1

Taking everything into account, ATON scores 1 out of 10 in our fundamental rating. ATON was compared to 534 industry peers in the Biotechnology industry. ATON may be in some trouble as it scores bad on both profitability and health. ATON is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ATON had negative earnings in the past year.
In the past year ATON has reported a negative cash flow from operations.
In the past 5 years ATON always reported negative net income.
In the past 5 years ATON always reported negative operating cash flow.
ATON Yearly Net Income VS EBIT VS OCF VS FCFATON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -304.13%, ATON is doing worse than 93.63% of the companies in the same industry.
Industry RankSector Rank
ROA -304.13%
ROE N/A
ROIC N/A
ROA(3y)-459.4%
ROA(5y)-279.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATON Yearly ROA, ROE, ROICATON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2K 4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATON Yearly Profit, Operating, Gross MarginsATON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for ATON has been increased compared to 1 year ago.
The number of shares outstanding for ATON has been reduced compared to 5 years ago.
ATON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ATON Yearly Shares OutstandingATON Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
ATON Yearly Total Debt VS Total AssetsATON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

ATON has an Altman-Z score of -142.32. This is a bad value and indicates that ATON is not financially healthy and even has some risk of bankruptcy.
ATON has a worse Altman-Z score (-142.32) than 97.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -142.32
ROIC/WACCN/A
WACCN/A
ATON Yearly LT Debt VS Equity VS FCFATON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 2.02 indicates that ATON has no problem at all paying its short term obligations.
The Current ratio of ATON (2.02) is worse than 74.72% of its industry peers.
A Quick Ratio of 2.02 indicates that ATON has no problem at all paying its short term obligations.
ATON's Quick ratio of 2.02 is on the low side compared to the rest of the industry. ATON is outperformed by 73.03% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 2.02
ATON Yearly Current Assets VS Current LiabilitesATON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 92.66% over the past year.
EPS 1Y (TTM)92.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ATON Yearly EPS VS EstimatesATON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATON. In the last year negative earnings were reported.
Also next year ATON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATON Price Earnings VS Forward Price EarningsATON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATON Per share dataATON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3 -4 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ATON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALPHATON CAPITAL CORP

NASDAQ:ATON (10/24/2025, 8:09:48 PM)

After market: 5.09 -0.04 (-0.78%)

5.13

+0.01 (+0.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-21 2025-10-21
Earnings (Next)11-24 2025-11-24
Inst Owners1.75%
Inst Owner ChangeN/A
Ins Owners31.57%
Ins Owner ChangeN/A
Market Cap30.16M
Revenue(TTM)N/A
Net Income(TTM)-6767000
Analysts43.33
Price TargetN/A
Short Float %0.44%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.72
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)-0.93
FCFYN/A
OCF(TTM)-0.93
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -304.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-459.4%
ROA(5y)-279.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 2.02
Altman-Z -142.32
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.91%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.8%
OCF growth 3YN/A
OCF growth 5YN/A

ALPHATON CAPITAL CORP / ATON FAQ

What is the fundamental rating for ATON stock?

ChartMill assigns a fundamental rating of 1 / 10 to ATON.


Can you provide the valuation status for ALPHATON CAPITAL CORP?

ChartMill assigns a valuation rating of 0 / 10 to ALPHATON CAPITAL CORP (ATON). This can be considered as Overvalued.


What is the profitability of ATON stock?

ALPHATON CAPITAL CORP (ATON) has a profitability rating of 0 / 10.


How financially healthy is ALPHATON CAPITAL CORP?

The financial health rating of ALPHATON CAPITAL CORP (ATON) is 3 / 10.